G807-0300 Screening compound: 5-ethyl-6-methyl-2-({[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)pyrimidin-4-ol

G807-0300 Screening compound: 5-ethyl-6-methyl-2-({[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)pyrimidin-4-ol
G807-0300 Screening compound: 5-ethyl-6-methyl-2-({[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)pyrimidin-4-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound G807-0300
5-ethyl-6-methyl-2-({[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)pyrimidin-4-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G807-0300

Molecular Formula

C19H22N4O5S (C19 H22 N4 O5 S)

Compound Name

5-ethyl-6-methyl-2-({[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}sulfanyl)pyrimidin-4-ol

IUPAC name

5-ethyl-6-methyl-2-({[3-(345-trimethoxyphenyl)-124-oxadiazol-5-yl]methyl}sulfanyl)pyrimidin-4-ol

SMILES

CCc(c(C)nc(SCc1nc(-c(cc2OC)cc(OC)c2OC)no1)n1)c1O

InChI

InChI=1S/C19H22N4O5S/c1-6-12-10(2)20-19(22-18(12)24)29-9-15-21-17(23-28-15)11-7-13(25-3)16(27-5)14(8-11)26-4/h7-8H,6,9H2,1-5H3,(H,20,22,24)

InChI Key

UMSINJPLEJDZQI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27162046

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.47

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.501

Distribution Coefficient, logD

3.469

Water Solubility, LogSw

-3.67

Polar Surface Area

89.118

Acid Dissociation Constant (pKa)

8.52

Base Dissociation Constant (pKb)

2.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.80

G807-0300 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with G807-0300 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G807-0300?
Check Price and Availability of G807-0300, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G807-0300 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G807-0300
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G807-0300
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G807-0300 available by request